Saturday, 24 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDrug

3D Medicines Secures Registration for Envafolimab in Macau for Advanced Solid Tumors

October 27, 2024
CompanyDrug

Hope Medicine Initiates Phase II Trial for HMI-115 in Endometriosis Treatment

October 27, 2024
CompanyDrug

Neuboron Medtech Secures Clinical Trial Approval for First BNCT Drug in China

October 27, 2024
Company

AstraZeneca China Announces Leadership Changes and New Biopharmaceutical Unit

October 27, 2024
CompanyDrug

SciClone’s Partner Menarini Files for Elacestrant Approval in Macau for Advanced Breast Cancer

November 10, 2024
Policy / Regulatory

China’s State Council Unveils 26 Initiatives to Enhance Grey-hair Economy

October 27, 2024
CompanyDeals

China Grand Pharma to Acquire 63% Stake in Duoputai for RMB 442 Million

October 27, 2024
CompanyDrug

Bayer’s Asklepios BioPharmaceutical Launches Phase II Trial for AAV Therapy in Heart Failure

October 27, 2024
CompanyDrug

CanSino Biologics Enrolls First Patient in Phase I Trial of Innovative Polio Vaccine

December 23, 2024
CompanyDeals

Novartis Acquires Calypso Biotech for USD 250 Million to Bolster IL-15 Pipeline

October 27, 2024
CompanyDeals

Cytokinetics Attracts Big Pharma Interest Amid Aficamten’s Phase III Success

October 27, 2024
CompanyDrug

RemeGen Secures Fast-Track Designation for RC88 in Platinum-Resistant Ovarian Cancer

October 27, 2024
1 2 … 13 14 15 16 17 … 27 28
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up